Best of the Blog: IN VIVO, April 2009

A selection of our favorite blog posts from April 2009 for stories not covered elsewhere in this month's IN VIVO. (See them for free at http://invivoblog.blogspot.com/).

Best of the Blog is a monthly column highlighting the best of our free online content at www.windhover.com/blog. In April, Windhover’s editorial staff posted 35 articles to the site, covering biopharma, device and diagnostics R&D, business development, regulatory and commercial news. Highlights included coverage of our annual Pharmaceutical Strategic Outlook meeting as well as the evolving swine flu pandemic. We also posted a podcast with Pfizer’s R&D chiefs Martin Mackay and Mikael Dolsten. Here are a few of our favorite blog posts and excerpts for stories not covered elsewhere in this month’s IN VIVO.

(April 9.) ...in fact it cushions them from doing much development activity at all, it seems.

More from Archive

More from In Vivo

Rising Leaders 2025: Doxie Jordan, From UNC Graduate To Global Market Strategist

 
• By 

Bristol Myers Squibb executive Doxie Jordan discusses his path to global commercial leadership and the principles guiding pharmaceutical market strategy

Podcast: Brain+ CEO Discusses “Groundbreaking” Potential Of CST Assistant For Dementia Patients

 

Devika Wood, CEO of Brain+, explains the importance of developing health tech solutions for dementia and the growing need to both raise awareness and improve overall access to nondrug interventions like CST.

Behind The Buyout: Dispatches From The Dealmaking Table

 
• By 

In a challenging funding environment for biopharma, strategic dealmaking has become a critical growth engine. In Vivo explores what it truly takes to navigate high-stakes acquisitions and partnerships, drawing on insights from seasoned industry leaders.